Taiwan registry for people treated for hepatitis C
Part of Digestive system, Infections clinical trials.
This registry is for people in Taiwan who have received direct-acting antiviral (DAA) treatment for hepatitis C. It collects health information to better understand outcomes and care, and you can join if you agree to participate and sign consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated for hepatitis C with DAA medicines
- You are willing to participate in a long-term health information registry
- You agree to sign written informed consent
- You are likely able to provide participation details as requested by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a pregnancy registry that collects information about people who have hepatitis C during pregnancy and took hepatitis C medicines early in pregnancy. It aims to better understand the safety and outcomes of treatment around conception.
This study is a registry, meaning it collects health information from people living with hepatitis B rather than giving a new treatment. It may help researchers better understand different hepatitis B groups and outcomes over time.
This study looks at people in China who have hepatitis D, a liver infection. It aims to learn more about the disease and how it affects people, which may help improve future care.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This study focuses on screening, treating, and eliminating hepatitis C. It is for people who may be at risk or newly diagnosed, and aims to connect them with care that could help clear the virus.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
Hear when a new Hepatitis C, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.